BioScale, a manufacturer of protein measurement technology, disclosed in SEC filings that it raised $5. 2 million convertible debt 37 separate investors participated in the bid
BioScale was founded in 2002 by Mark Lundstrom, CEO, and three interdisciplinary MIT professors. Since then, the Company has put together a development, engineering, manufacturing and industrially seasoned commercial team to launch its AMMP assay technology and ViBE platform globally in the pharmaceutical, biotech, life sciences and bioprocess markets. We are also pursuing partnerships for diagnostic and specialty applications The company’s new 30,000 square Uh, ft Global headquarters and manufacturing facilities are located in Lexington, Massachusetts.
Please note that this piece of work originally appeared in English at https://www.vcnewsdaily.com/BioScale/venture-funding.php. As Investocracy aims to bring global startup news and updates in both English and Japanese to you, it’s important that we attribute original source to you. If you have any questions/concerns please write to us at contact@investocracy.co
Singapore has always had a progressive healthcare system with prioritizing innovative solutions to the existing…
A Ponzi scheme is a fraudulent investment scheme that aims to give its investors high…
According to the Global Prop tech Survey, 2019 published by KPMG one of the key…
In April 2016, the world witnessed one of the biggest information leaks in history, consisting…
Silent Eight a global technology company that helps combat money laundering and terrorism financing using…
Indian startup Gully Network Retail Pvt Ltd, a retail-tech startup focused on providing services to…
Leave a Comment